To include your compound in the COVID-19 Resource Center, submit it here.

NGR-hTNF: Additional Phase II data

Additional data from the open-label, Italian Phase II NGR010 trial in 57 relapsed patients showed that 0.8 µg/m 2 IV NGR-hTNF

Read the full 211 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE